Given the important role of miR-33 and NF-κB pathway in cholesterol metabolism and inflammation, we postulated that TFA may inhibit atherosclerosis through regulating miR-33 expression and NF-κB pathway. This evidence concerns the gene NFKB1 and atherosclerosis.